Navigation Links
Telik Announces Initiation of a Phase 2b Clinical Trial of Telintra® (Ezatiostat HCL) in Patients With Low to Intermediate-1 Risk Non-Deletion (5q) Myelodysplastic Syndrome
Date:10/13/2011

nology, TRAP®, which enables the rapid and efficient discovery of small molecule drug candidates.

This press release contains "forward-looking" statements regarding the future development of Telintra, the safety and effectiveness of Telintra in treating MDS, whether Telintra treatment results in hematologic improvement in patients with MDS, whether Telintra treatment results in transfusion reduction or independence or offers an alternative to blood transfusions, and the enrollment of patients in, and data relating to, the clinical trials described above. These forward-looking statements are based upon Telik's current expectations and there are important factors that could cause actual results to differ materially from those indicated by these forward-looking statements. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release may be found in Telik's periodic filings with the Securities and Exchange Commission, including the factors described in the section entitled "Risk Factors" in its quarterly report on Form 10-Q for the period ending June 30, 2011. Telik does not undertake any obligation to update forward looking statements contained in this press release.

TELIK, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trademarks of Telik, Inc.


'/>"/>
SOURCE Telik, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Telik Announces Publication in the Journal Cancer of a Phase 2 Randomized Multicenter Study of Two Extended Dosing Schedules of Oral Ezatiostat in Low to Intermediate-1 Risk Myelodysplastic Syndrome
2. Telik Announces First Quarter 2011 Financial Results
3. Telik Announces Presentation of New Data on the Characterization of Novel Ezatiostat (TELINTRA®, TLK199) Analogs at American Association for Cancer Research Annual Meeting
4. Telik Announces Presentation and Webcast at 10th Annual Needham Healthcare Conference
5. Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance
6. Telik Announces Presentation and Webcast at 13th Annual BIO CEO & Investor Conference
7. Telik Announces Presentation at American Society of Hematology Annual Meeting
8. Telik Announces Third Quarter 2010 Financial Results
9. Telik Awarded $1.2 Million in Grants for Qualifying Therapeutic Development Projects
10. Telik Announces Publication of Review Focused on the Inhibition of the Enzyme GSTP1-1 as a Target for New Cancer Treatments
11. Telik Announces Publication of a Case Report of a Sustained Hematologic Response in Myelodysplastic Syndrome Following an Abbreviated Exposure to Oral Telintra(R) (Ezatiostat HCl)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 26, 2014  Aethlon Medical, Inc. ... definitive agreement to raise approximately $3.3 million at a ... made by one institutional healthcare focused investor. Each unit consists ... a common share purchase warrant. Each whole warrant entitles ... price of $0.30 for a period of five years ...
(Date:11/26/2014)... , Nov. 26, 2014  Cohen, Placitella ... behalf of investors who purchased Nymox Pharmaceutical Corporation ... during the period from January 31, 2011 through ... whether Nymox and certain of its officers and ... in violation of Sections 10(b) and 20(a) of ...
(Date:11/26/2014)... , Nov. 26, 2014 Lexicon ... announced the completion of previously announced concurrent financing ... After fees and estimated offering expenses, Lexicon anticipates ... transactions.  The transactions consisted of: , ... stock, pursuant to a registration statement that has ...
Breaking Medicine Technology:Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3
(Date:11/26/2014)... November 26, 2014 Healthpointe is proud ... Perris , and it will be led by ... in the field of Occupational Medicine and utilizes the ... Medicine specialist delivers quality care for employers and their ... health. , As an Occupational Medicine ...
(Date:11/26/2014)... Recently, Locks-Magnetic.com, a Chinese outstanding Maglocks supplier, is ... on the Internet. It also provides a big discount ... As a leading company in the electronic lock industry, ... buy high quality locks. It can meet the demands ... are not only useful but also affordable. However, inexpensive ...
(Date:11/26/2014)... iFitDress.com, a well-known wedding dress manufacturer and ... 16 cocktail dresses . Included in the new range ... all of these charming outfits are offered at deeply ... has promised that all of the sweet 16 cocktail ... worth mentioning that all of them are set according ...
(Date:11/26/2014)... November 26, 2014 Dr. Rod ... Distinguished Teaching Professor in the Department of Plastic ... facial fat compartments, fat grafting, and modern lift-and-fill ... an annual conference held by the American Society ... of this underlying facial structure were explored in ...
(Date:11/26/2014)... When you,re planning your holiday get-away, don,t forget ... -- such as skiing or hiking, a sports ... fail to take altitude into account when visiting ... of developing fatigue and other symptoms related to ... Melissa Tabor, an assistant professor of sports medicine ...
Breaking Medicine News(10 mins):Health News:Healthpointe now offering Occupational Medicine in their Perris Medical Clinic 2Health News:Healthpointe now offering Occupational Medicine in their Perris Medical Clinic 3Health News:Fresh Products Launched by Famous Company Lock-Magnetic.com 2Health News:iFitDress.com: Trendy Sweet 16 Cocktail Dresses Unveiled 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 3Health News:Don't Let High Altitude Ruin Your Holiday Trip 2
... year in Jacksonville,nearly 600 adults experience some form ... to recovery lacked long-term support. Today, Brooks,Rehabilitation celebrated ... Florida created to help people with acquired brain ... The Brain Injury Association of America estimates that ...
... researcher, administrator, and,Chair Emeritus of the University of Louisville,s ... Foundation for,Biomedical Research (FBR) today announced its board of ... chairman of the board. Dr.,Polk succeeds the late Dr. ... years., "I am honored to represent the Foundation ...
... respiratory problems, CDC report says , , WEDNESDAY, Oct. 22 (HealthDay ... has soared 18 percent in the last decade, with an ... the condition, a new federal report says. , In 2007, ... reported to have had a food or digestive allergy in ...
... Oct. 22 Endocare, Inc.,(Nasdaq: ENDO ), an ... invasive technologies for tissue and tumor,ablation, today announced that ... Oppenheimer 19th Annual Healthcare Conference at 1:20,p.m. ET on ... at the,Waldorf Astoria hotel November 3-4 in New York ...
... supplier, DRE adds affordable, professionally refurbished ultrasound machines to its ... ... KY (PRWEB) October 22, 2008 -- DRE Inc. - named ... businesses in Louisville, Ky. — now sells professionally refurbished ...
... allows more efficient use of larger cleanrooms. , ... ... fabricator and installer of cleanrooms and cleanroom equipment announces ... the AireCell line of extrusions. The new extrusion allows greater ...
Cached Medicine News:Health News:Brooks Rehabilitation Opens First Work-Based Brain Injury Rehab Program in Florida 2Health News:The Foundation for Biomedical Research Names Dr. Hiram C. Polk Jr. Chairman of its Board of Governors 2Health News:Food Allergies Up 18% Among U.S. Children 2Health News:Endocare to Present at Oppenheimer 19th Annual Healthcare Conference 2Health News:DRE Medical Equipment Adds Affordable Refurbished Ultrasound Machines to Product Line 2Health News:DRE Medical Equipment Adds Affordable Refurbished Ultrasound Machines to Product Line 3Health News:Gerbig Engineering Introduces 7 " Deep Extrusions for Cleanroom Construction 2
The pouch is designed to protect the Digitrapper. The pouch strap can be worn on a belt loop or carried in a shoulder strap or backpack configuration....
... catheters are designed using established technology ... following benefits:, ,Working with pH ... where the multi-use catheter is used ... contact to the skin.,NOTE: ,Medtronic pH ...
...
... Designed to accommodate a variety of applications ... the AMAX DestinyPlus is suitable for any ... environment. With a mixed-mode throughput exceeding 95 ... perform a full range of chromogenics, the ...
Medicine Products: